Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

econd quarter of 2010, primarily due to higher non-GAAP profit from operations, which was partially offset by lower other income.  

Diluted earnings per ADS were $0.18, which compares with $0.26 in the second quarter of 2010.  

Non-GAAP diluted earnings per ADS were $0.25, which compares with $0.28 in the second quarter of 2010.

Financial Position  As of June 30, 2011, the Company had cash and cash equivalents of $41.6 million and short term debt of $0.8 million. During the quarter, capital expenditures totaled $11.0 million, including $5.5 million related to the purchase of a 68,000 square foot new lab and office building which replaced the original 36,000 square foot facility in Chengdu. The purchased lab and office building allows us to reduce overall expenditures and improve our earnings over time.  With a strong balance sheet and sound financial position, the Company is well positioned to make targeted investments when opportunities arise.  

Full Year 2011 GuidanceThe Company reconfirms its guidance for full year 2011.  The Company expects:

  • Net revenues to be approximately $111.1 – $115.6 million, which represents growth of approximately 23.0% – 28.0% compared with full year 2010.  
  • Non-GAAP gross margin to be approximately 33.5% – 35.5%, which is within the same range as non-GAAP gross margin of 34.5% in 2010.
  • Capital expenditure to be $28 - $32 million, including $6 million rolling payment lag impact carried forward from 2010.

  • This reflects the Company's current view and is subject to change.

    Conference CallShangPharma will host a conference call and live webcast at 8am New York time on August 22, 2011 (8pm Beijing time on August 22, 2011).  A PowerPoint presentation accompanying the prepared remarks will be available on the Company's website shortly before the call.  

    The dial-in details
    '/>"/>

    SOURCE ShangPharma Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

    Related biology technology :

    1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
    2. ShangPharma Announces First Quarter 2011 Results
    3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
    4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
    5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
    6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
    7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
    8. Neurologix Announces Second Quarter 2011 Financial Results
    9. Bion Announces New U.S. Patent for Phosphorus Removal
    10. ViaCyte Announces Executive Management Changes
    11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... Sept. 19, 2014  An entire month is dedicated ... neuropathies – Charcot-Marie-Tooth disease (CMT) – a debilitating neuromuscular ... extreme muscle atrophy, weakness, and foot and hand deformities. ... millions worldwide. CMT is a progressive disease, and over ... requiring mobility devices such as leg braces, wheelchairs and ...
    (Date:9/19/2014)... Barnhardt Manufacturing Company has ... Organic Cotton . The USDA Certified Biobased Product ... ingredients meets or exceeds levels set by USDA. Biobased ... or in significant part of agricultural, forestry, or marine ... cotton to be immediately identified as a USDA certified ...
    (Date:9/18/2014)... September 18, 2014 Bipartisan passage this ... bill designed to stimulate development and commercialization of new ... praised by leaders of SPIE, the international society ... American Manufacturing and Innovation (RAMI) Act, now moves to ... have said they are optimistic that it will win ...
    (Date:9/18/2014)... , Sept. 18, 2014  Health Enhancement Products, Inc. (OTCQB: ... early-stage algae bioactive compounds and metabolic processes, is pleased to ... board of directors. Ms. Nola E. Masterson , a ... joined the board effective September 17, 2014. ... to join our board," states Andrew Dahl , President ...
    Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2
    ... July 28, 2011 As the fight over deficit reform ... Association (NEBA) is urging lawmakers from across the region to ... economy and ensure it doesn,t become a victim of short-sighted ... options for treatment and medications available to seniors, but would ...
    ... (NASDAQ: ITMN ) today announced that it will ... 4, 2011. A live conference call and webcast will be ... day to discuss business highlights and financial results for the ... To access the live teleconference, dial 888-567-5125 (U.S.) or 706-643-9223 ...
    ... INDIANAPOLIS, and WALTHAM, Mass., July 28, 2011 ... Eli Lilly and Company (NYSE: LLY ) and ... the companies have submitted their reply to a complete response ... Drug Administration (FDA) regarding BYDUREON™ (exenatide extended-release for injectable suspension), ...
    Cached Biology Technology:Biotech Group Warns Proposed Medicare Cuts Could Hurt Critical Sector of New England Economy 2InterMune to Release Second Quarter Financial Results on August 4 2BYDUREON™ Reply Submitted to FDA 2BYDUREON™ Reply Submitted to FDA 3BYDUREON™ Reply Submitted to FDA 4BYDUREON™ Reply Submitted to FDA 5BYDUREON™ Reply Submitted to FDA 6BYDUREON™ Reply Submitted to FDA 7
    (Date:9/18/2014)... disciplines will be celebrated tonight at the third annual ... the health of premature infants and in paving the ... whose work was supported by the National Science Foundation, ... Energy Commission, will be honored at a ceremony at ... group of Members of Congress will be on hand ...
    (Date:9/18/2014)... and nitrogen comprise all spheres of our planet. ... caused imbalances and perturbations that resulted in increases ... result in climate changes which influence the complex ... atmosphere. Understanding these feedback mechanisms has become an ... during the past three decades. , In parallel, ...
    (Date:9/18/2014)... it that when people are too stressed they are ... the Brain Mind Institute (BMI) at EPFL have just ... between chronic stress and the loss of social skills ... attacks a synaptic regulatory molecule in the brain. This ... Communications . , Carmen Sandi,s team went to ...
    Breaking Biology News(10 mins):3rd annual Golden Goose award ceremony honors 8 researchers; Unusual work had big results 2Greenhouse gas research enters a new era 2How stress tears us apart 2
    ... infected with human immunodeficiency virus (HIV), highly active ... of Kaposi sarcoma and non-Hodgkin lymphoma, according to ... of the Journal of the National Cancer Institute. ... (AIDS) have reported increased risks of several cancers, ...
    ... phase 3 HIV vaccine efficacy trial are reported in the ... available online. Although the vaccine was ineffective in preventing HIV ... HIV and offers the scientific community a foundation on which ... the United States and the Netherlands and completed in 2003, ...
    ... University of Pennsylvania School of Medicine have identified a ... Virus (EBV) protein known to be expressed in a ... mechanism by which EBV transforms human B cells from ... to development of B-cell lymphomas. , Erle S. Robertson, ...
    Cached Biology News:Antiretroviral therapy may prevent excess risk of some cancers in people with HIV 2HIV vaccine trial breaks ground for future research 2Epstein-Barr virus protein crucial to its role in blood cancers 2
    ... applications for the use of small interfering ... via the RNA interference (RNAi) pathway have ... molecular biology fields. siRNA for experimental use ... or enzymatically, and then transfected into the ...
    ... is commonly used as a fusion partner ... The GSTTag sequence has been reported to ... the solubility of its fusion partners. When ... GSTTag fusion proteins can be purified with ...
    a1-Antitrypsin (human, alpha-1 AT)...
    ... demands of the routine trace metal analytical ... robust and simple to use instrumentation. The ... most challenging sample matrices found in the ... the toughest analytical challenges found in the ...
    Biology Products: